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Pulmonary embolism (PE) is a major health problem associated with a significant morbidity
and mortality. Immediate recognition of submassive and massive cases is extremely
important in order to commencement of early and appropriate therapy that could be life
saving. The aim of this study was to assess the ability of two scoring systems,
electrocardiography (ECG) and simplified Wells (sWells) clinical scorings in predicting
anatomic severity of PE. Hence, ECG and sWells scorings were combined in order to test
the hypothesis if this new scoring does enhance the prediction of severity. Fifty six patients
with proven PE with high (50 patients) and moderate (six patients)—probability of
ventilation/perfusion (V/Q) scan were retrospectively studied. Baseline ECGs were
analysed by two independent observers in order to constitute ECG scorings. Baseline
sWells scores were also calculated. Anatomic severity of PE was calculated by
scintigraphically and categorized into mild (o50% perfusion defect) (group 1), and severe
(X50% perfusion defect) (group 2) diseases. The mean of ECG scores, sWells scores and the
combined scores were 5.2373.42 and 5.8573.82; 6.6071.88 and 7.0372.40; and
10.7373.60 and 11.6074.32 in groups 1 and 2, respectively (p40.05). An ECG score of 6.5
predicted severe disease (perfusion defect X50%) with a sensitivity of 41.7% and a
specificity of 82%). sWells and combined scores did not provide better sensitivity or
specificity values based on ROC curve analysis. Our results indicated that ECG scoring could
be valuable test in predicting anatomic severity of PE, adding sWells scoring to ECG scoring
did not provide any beneficial effect.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Table 1 Wells scoring method.
Item Points
Clinical signs and symptoms of DVT (minimum of
leg swelling and pain with palpation of deep
veins)
3
An alternative diagnosis is less likely than PE 3
Heart rate greater than 100 1,5
Immobilization or surgery in the previous 4 weeks 1,5
Previous DVT/PE 1,5
Hemoptysis 1
Malignancy (on treatment, treated in last 6
months or palliative)
1
Low pretest probability (PTP) (o2 points), intermediate PTP
(2–6 points), and high (46 points).
A. Kanbay et al.1172Introduction
Pulmonary embolism (PE) is associated with both early and
late morbidity and mortality that resulted from cardiopul-
monary disease. The high incidence of PE requires physicians
to maintain a high level of suspicion to make a prompt
diagnosis and begin appropriate treatment. However,
accurate and rapid diagnosis of PE remains difficult in
clinical practice.1 Undiagnosed PE patients have a hospital
mortality rate as high as 30%. This rate falls to nearly 8%
when diagnosed and treated appropriately.2–4 Wells et al.
described a clinical model to determine the pretest
probability for PE using clinical findings, electrocardiogra-
phy (ECG), and chest radiography.5 The prevalence of PE in
high probability subgroup is 78%.6 Wells scoring system has
now become a fundamental principle testing to consider the
likelihood of PE.
PE is described as severe when pulmonary arterial
obstruction affects the hemodynamics of the right side of
the heart and gas exchange. Mortality rates exceed 50% in
such patients.7 Immediate recognition of this condition is
extremely important in order to commencement of early
and appropriate therapy which could be life saving. Severe
cases can be verified by ECG with abnormal changes. ECG,
could be served as an ubiquitously available and also first-
line test to raise suspicion of severe PE and lead to further
risk stratifying tests such as biomarkers, echocardiography
(ECHO), or spiral computerized tomography (CT). In a recent
study an ECG scoring system based on electrocardiographic
abnormalities has been defined in order to recognize severe
PE cases.8
The correlation between Wells score and the severity of
PE has not been investigated previously. Both Wells score
and ECG scoring systems are ubiquitously available for the
first assessment of the patients with suspicious diagnosis of
PE. We therefore examined the clinical utility of ECG and
the simplified Wells (sWells) score to assess the ability to
predict severe PE. ECG and Wells scoring were combined to
test whether this new scoring system enhances the predic-
tion of PE severity.
Materials and methods
Study population and design
This study was carried out in the Department of Pulmonary
Medicine at Gazi University School of Medicine in Ankara,
Turkey. Lung scan records of patients with proven diagnosis
of PE between January 2001 and May 2004 were reviewed.
The diagnosis of PE was established when a high or moderate
probability ventilation-perfusion scan had been obtained
according to previously published protocol by Prospective
Investigation of Pulmonary Embolism Diagnosis (PIOPED)
investigators.9 The medical records of these patients
including patient demographics, clinical signs and symp-
toms, and laboratory and radiographic test results were
reviewed. Patients were excluded if no record of ECG had
been obtained within 48 h or if V/Q scan records were
not found.
The primary evaluating physician’s pretest probability for
PE was also recorded according to sWells scoring, which waspreviously described.5 The sWells score is a clinical pretest
probability score derived from large trials that sought to
determine the clinical signs and symptoms to reliably
predict a diagnosis of PE.6 Variables used in the calculation
of this score are presented in Table 1. We used the authors’
definitions of high, intermediate, and low probability of PE.
The sWells score was calculated retrospectively by an
investigator who blinded to V/Q scan results.
The ECG scoring system has been previously described by
Daniel et al. (Table 2). Briefly, it was based on four
abnormalities that were previously shown to be associated
with massive PE; sinus tachycardia, incomplete and com-
plete right bundle branch block, T wave inversion and
S1Q3T3.10 The relative weight of each criterion was set on
the basis of the expected importance of each abnormality in
the distinction of patients with massive PE from patients
with submassive PE or no PE.10 All ECGs were obtained
within 48 h of V/Q scan. Two individuals trained in the
interpretation of ECG results scored the ECG independently.
Both were blinded to the V/Q scan interpretation.
A combined scoring system (the ECG score added to the
sWells score) that used to determine the severity of PE was
calculated in this study. We removed the parameter of the
heart rate from the sWells score and added the calculated
ECG score to the remaining sWells score in order to create a
new combined score (Table 3).
The minimum and maximum scores for sWells score, ECG
scoring system and combined scoring system were 0–12.5,
0–21 and 0–32, respectively.
To calculate the areas with perfusion defect on the lungs,
perfusion imaging used for the diagnosing. Perfusion imaging
was performed using a 99mTc-macroaggregated albumin
technique. Ventilation studies were performed using an
aerosol technique with 99mTc-diethylene-triamine penta-
acetic acid. On both the ventilation and perfusion studies,
six standard views were obtained with a gamma camera.
Anatomic severity of PE was blindly and retrospectively
evaluated with a calculation of a PVO score (PVOs) using
scintigraphic images. The calculation was done according to
previously published protocol.8 Briefly, each lobe was
assigned a weight based on the regional distribution of
pulmonary blood flow in the supine position. For each lobe,
a semi-quantitative perfusion score from 0 to 1 (0, 0.25, 0.5,
0.75, and 1) was estimated. Each lobar perfusion score was
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Table 3 Combined scoring method.
Item Points
Clinical signs and symptoms of DVT (minimum of
leg swelling and pain with palpation of deep
veins)
3
An alternative diagnosis is less likely than PE 3
ECG score
Immobilization or surgery in the previous 4 weeks 1,5
Previous DVT/PE 1,5
Hemoptysis 1
Malignancy (on treatment, treated in last 6
months or palliative
1
Total score (maximum ¼ 32)
Table 2 ECG Scoring method.
Characteristics Score
Tachycardia (4100 beats/min) 2
Incomplete right bundle-branch blocka 2
Complete right bundle-branch blockb 3
T-wave inversion in lead V1–V4 4
T-wave inversion in lead V1 (mm)
o 1 0
1–2 1
42 2
T-wave inversion in lead V2 (mm)
o1 1
1–2 2
42 3
T-wave inversion in lead V3 (mm)
o 1 1
1–2 2
42 3
S wave in lead 1c 0
Q wave in lead 3d 1
Inverted T wave in lead 3 1
If all of S1Q3T3 2
Total score (maximum ¼ 21)
aQRS complex of 0.10–0.11 s and an S wave in lead 1 and
terminal R wave in V1 41.5mm.
bQRS40.11 s and S wave in 1 and terminal R wave in
V141.5mm.
cFirst negative deflection after an R wave41.5mm.
dFirst negative deflection after the P wave and before any
R wave41.5mm.
Electrocardiography and Wells scoring in PE 1173then calculated by multiplying the weight by the perfusion
score. The overall perfusion score was determined by
summing the six separate lobar perfusion scores. The
percentage of vascular obstruction by perfusion scanning
was then calculated as: PVOs (%) ¼ (1-overall perfusion
score).8 PVOso50% were defined as mild disease (group 1),
and PVOsX50% were defined as severe disease (group 2).
The cut-off values of three used scoring system scores were
calculated in order to estimate the sensitivity and specificity
to predict the diagnosis of severe patients. Two blindindividuals trained in the interpretation of V/Q scan
calculated the PVOs independently.
Echocardiographic records have been obtained in a total
of 47 patients; 37 in group 1 and, 10 in group 2. Any ECHO
findings of PE, such as right ventricular hypokinesis or
akinesis, right ventricular dilatation, interventricular septal
paradoxical movement and pulmonary hypertension, were
coded as abnormal findings.11 None of the patients had
patent foramen ovale.
Statistical analyses
SPSS software (Statistical Package for the Social Sciences,
version 10.01, SSPS Inc, Chicago, IL, USA) was used for
statistical analyses. Statistical results are given as means 7
SD. The Student t test was used for a comparison of
parametric values. Interrater reliability was assessed by the
Cronbach a for the ECG scores and k for the perfusion
subgroups. The diagnostic accuracy of the ECG score, the
sWells score, and the combined score in predicting those
with X50% perfusion defect are expressed as a receiver
operator characteristic (ROC) curve. This enabled sensitiv-
ities and specificities to be calculated for different ECG,
Wells, and combined scores. Pearson’s correlation test was
used to analyze the relation between different numeric
parameters. Chi-square and Fisher’s exact chi-square were
used for group comparisons. A p-value less than 0.05 was
considered statistically significant.
Results
We reviewed 123 patients’ records with proven PE. Sixty-
seven records were excluded from study. The reason of
exclusion is (1) no ECG was recorded within 48 h of the scan
in 26 patients, (2) the diagnosis of PE was made by
computed tomography in 39, and (3) the V/Q scan could
not be located in two patients. The study group included the
remaining 56 patients (25 men and 31 women; mean age,
58.28716.73 years; range, 21–86 years) who diagnosed with
V/Q scan. None of the patients had previous history of
chronic obstructive pulmonary disease and myocardial in
farction.
The history of previous surgery and immobilization were
present in 31 (56.4%) and postpartum period were present in
two (3.6%) of the patients. Malignancy was seen in two
patients (3.6%), deep vein thrombosis (DVT) was present in
20 (35.7%), and previous venous thromboembolic disease
was present in 13 (23.2%) of the patients, respectively.
According to the result of V/Q scan, six patients had
moderate and 50 patients had high-probability V/Q scans. Of
the moderate scans, five were confirmed by CT. In the other
case, high D-dimer level with DVT and severe hypoxemia were
present. By consensus, 42 patients (75%; mean age,
55.40719.99 years) were categorized as PVOso50% (group 1)
and 14 patients (25%, mean age, 66.92712.99 years) were as
PVOsX50% (group 2). The interobserver agreement for the
calculation PVOs was quite strong (k ¼ 0:948).
Regarding to the clinical symptoms, 51/56 (91.1%), 16/56
(28.6%), 46/56 (82.1%), 42/56 (75%), 10/56 (17.9%), 12/56
(21.4%) of the patients had dyspnea, hemoptysis, chest
pain, tachicardia, cough and syncope, respectively. The
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Figure 1 Comparative sensitivity and specificity of three
methods.
A. Kanbay et al.1174distribution of the symptoms did not reach statistical
significance between the two groups.
Some of the clinical and laboratory findings of the
patients are shown in Table 4. The correlation between
PVOs and P (A-a) O2 gradient (r ¼ 0:540; p ¼ 0:001) and,
PVOs and mean PAP (r ¼ 0:372; p ¼ 0:043) reached statistical
significance.
All (n ¼ 10) patients in group 2 had right ventricular
dilatation and at least one ECHO abnormalities compared to
16/37 (43.2%) and 21/37 (56.8%) of the patients in group 1
(p ¼ 0:01, p ¼ 0:001, respectively).
All of the patients except two were discharged with
recovery under anticoagulant therapy. Although appropri-
ately anticoagulated, two patients died due to PE. The PVOs
scores of two death patients were 52.50% and 43.75%,
respectively.
The mean sWells scores were 6.6071.8 (SD 1.8) and
7.0372.40 (SD 2.4) for groups 1 and 2, respectively.
Differences of the sWells scores in groups 1 and 2 were not
statistically significant (t ¼ 0:490, p ¼ 0:49). To assess the
ability of mean sWells scores to predict patients with a
greater-than-50% perfusion defect, a ROC curve was con-
structed and the area under the curve was calculated
(AUC ¼ 0.42, P ¼ 0.413) (Fig. 1). When the cut-off point was
chosen for sWells as 6.5 the sensitivity was 33.3% and the
specificity was 55%. When the patients were stratified as
sWells score X ando6.5, there was no statistically
significant difference according to the ECHO findings
between the groups.
The mean ECG scores were 5.2373.42 (SD 3.4) and
5.8573.82 (SD 3.8) for groups 1 and 2, respectively.
Interobserver agreement for the ECG score was excellent
(Cronbach a ¼ 0:99). There was no statistically significant
difference between the groups (t ¼ 0.571, p ¼ 0.572). To
assess the ability of the mean ECG score to predict those
with aX50% perfusion defect, a ROC curve was constructed
(Fig. 1). The area under the curve was 0. 62 (p ¼ 0.184). An
ECG score of X3.5 indicated patients with a greater-than-
50% defect on lung scan with a sensitivity of 83.3% and
specificity of 46%. When the cut-off point was chosen as 6.5
the sensitivity was 41.7% and the specificity was 82%. When
the patients were stratified as patients with ECG score X
ando6.5; all (n ¼ 10) patients in higher score had at leastTable 4 Clinical and laboratory characterization of the patien
Severe pa
mean7 (S
Age (years) (range) 66.9273
Body temperature (1C) 36.770
Pulse (beats/min) 107.2174
Respiratory rate (breaths/min) 28.7171
Systolic blood pressure (mmHg) 111.7875
Diastolic blood pressure (mmHg) 66.0774
pH 7.4470
P (A-a) O2 pressure gradient 57.2472
Mean sPAP 56.7072
sPAP, systolic pulmonary arterial pressure.one ECHO abnormalities, right ventricular dilatation and
pulmonary hypertension compared to 21/37 (56.8%), 16/37
(43.2%) and 18/37 (48.6%) of the patients with lower ECG
score (x2 ¼ 6:556, p ¼ 0:01; x2 ¼ 10:260; p ¼ 0:01; x2 ¼
8:620; p ¼ 0:003, respectively).
The mean score of the combined scoring were
10.9573.77 (SD 3.6) and 11.6074.32 (SD 4.3) for groups 1
and 2, respectively. Differences between the groups were
not statistically significant (t ¼ 0.549, p ¼ 0.506). To assess
the ability of the combined score to patients with a greater-
than-50% perfusion defect, a ROC curve was constructed
(Fig. 1). The area under the curve was 0.582 (p ¼ 0.385).
When the cut-off point was chosen for combined score as
12.25 the sensitivity was 41% and the specificity was 73%.
When the patients were stratified as combined score X
ando12.5, there was no statistically significant difference
according to the ECHO findings between the groups.
Based on the ROC analysis, ECG scoring provided the best
results in predicting severe patients. Adding sWells scores to
ECG scores did not provide any beneficial effects (Fig. 1).
Hence, ECG score has better correlation with ECHO findings
compared to other scoring systems.ts with pulmonary embolism.
tients (n ¼ 14)
D)/n
Mild patients (n ¼ 42)
mean7(SD)/n
P
.47 55.4072.62 0.024
.22 36.9970.13 0.311
.06 101.1471.66 0.017
.25 28.0470.05 0.713
.82 113.3372.17 0.759
.39 71.6671.55 0.135
.01 7.4570.06 0.906
.73 35.8672.20 0.000
.96 46.8571.96 0.009
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Electrocardiography and Wells scoring in PE 1175Discussion
In the current study, we found that the ECG scoring system is
a more accurate diagnostic method for predicting severe PE
than are the sWells and combined scoring systems. The
sWells scoring was insufficient for detecting severity of PE.
Although it did not reach statistical significance, the
combined scoring system was shown to be better at
predicting anatomic severity.
The definition of PE severity ranges from the subjective
description of symptoms12 to the more objective determina-
tion of right ventricular dysfunction by ECG13,14 and ECHO.15
Tachycardia and incomplete right bundle branch block were
detected significantly more frequent in patients with PE.16
The functional severity of PE can be better predicted by
echocardiographic evaluation. Echocardiographic abnormal-
ities can reliably reflect the decreased cardiopulmonary
reserve of the patients.17 However, ECHO is not ubiquitously
available in every hour of a day to detect the severity of PE.
In previous studies, Iles et al.8 and Daniel et al.10 have
shown that an ECG scoring system could predict severity of
PE. Daniel et al. showed that ECG score showed significant
positive relationship to systolic pulmonary arterial pressure
(sPAP) in patients with PE proven by pulmonary angiography.
However, such correlation did not appear in the group of
patients with pulmonary hypertension but without PE. The
cut-off value of 10 gave 23.5% of sensitivity and 97.7% of
specificity for distinguishing patients who had sPAP4
50mmHg secondary to PE. These findings might reflect that
the ECG score might be a useful method distinguishing
severe pulmonary hypertension due to PE from other
reasons. These findings were also important in showing
higher scores had higher specificity for distinguishing severe
cases from mild ones. In our results, when the cut-off value
was described as 6.5, the ECG score was well associated
with ECHO findings. However, the other scoring systems did
not show such association.
Later, using the same ECG scoring system Iles et al.
showed in 229 patients that the ECG score of X3 predicted
patients with 450% perfusion defect in V/Q scan with a
sensitivity of 70% and a specificity of 59%. When the score
extended to X6 the sensitivity was 40% and specificity was
90%.8 These results were consistent to our results.
Both Iles et al. and Daniel et al. have concluded in their
study that ECG score does aid in identification of severe PE
cases. The method allows physicians to a quick and a
reliable assessment. Hence, Geibel et al.18 have showed in
508 patients, ECG parameters might reflect the outcome.
Multivariate analysis revealed in this study that the presence
of at least one of the ECG abnormalities was a significant
independent predictor of outcome besides homodynamic
instability, syncope and chronic pulmonary disease. Also
they concluded that their results supported that ECG may be
useful as a simple, non-costly initial tool for assessing the
patients’ prognosis and guiding further diagnostic work-up
and therapeutic decisions in clinical practice.
In the literature, several studies in PE.8,19–21 have clearly
shown that clinical scoring for suspected PE could be useful
in diagnosis; however, we found no study that aimed to
investigate prediction of severe PE with a clinical scoring
system. Therefore, in our study we tested this hypothesis
using a well-known clinical scoring, Wells scoring system.Wells et al. described first an extended score, which is
rather complex and not easy to use in daily practice and
subsequently they developed a simplified scores.6 On sWells
score, in 1260 patients and from 40 variables, seven were
found to be independently associated with the presence of
PE. When patients were categorized in as low, intermediate
and high clinical probability accordingly, the corresponding
rates of PE were 3.6%, 20.5% and, 66.7%, respectively.20 In
our study sWells score alone or the combination of ECG and
sWells did not enhance the prediction of severe PE cases.
Our study has several limitations: firstly, this was a
retrospective study, and data were obtained only from
records from pulmonary department. We did not have
database from surgical departments and other medical
departments. This restricts the number of study population.
Hence, a remarkable number of patients were not included
in the study due to incomplete data. Secondly, the patients
were unevenly distributed when stratified as V/Q scan
results. Most patients were in high probability V/Q scan
results, therefore patients with PE in intermediate and low
V/Q scans are yet to be evaluated. Thirdly, the ECG score is
likely to have its own limitations. The electrocardiographic
features of acute PE depend on the size of the embolus, its
hemodynamic effects, and on the underlying cardiopulmon-
ary reserve of the patient. Timing and frequency of
electrocardiographic recording also are important as any
changes may be transient.22 Also, a T-wave inversion, which
can vary in character, may be secondary to right bundle
branch block and is frequently found in leads V1 and V3 in
normal ECGs.23 During the study period, we encountered
atrial fibrillation in the ECG records of two patients. Because
the atrial fibrillation does not occupy a place in the ECG
scoring system, we excluded those patients from the study.
More studies are warranted to better elucidate the
pathophysiologic processes affecting right-sided cardiac
conduction and repolarization in the right ventricular
pressure and right ventricular subendocardial ischemia.24
So that studies prospectively designed accompanied with
ECHO findings probably give better view.
In conclusion, a high ECG score resulting from a majority
of the pulmonary vascular bed being occluded by throm-
boemboli with cardiac decompensation is an indicative of
severe PE. An ECG score of X 6.5 has a better specificity in
suggesting patients with a greater-than-50% perfusion
defect. Adding simplified Wells scoring to ECG scoring failed
to provide any significant benefit.References
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